Funded Tech Companies
Redesign Science
Wondering who backed Redesign Science? Morningside Group, Third Kind Venture Capital and Refactor Capital joined the equity holders in this innovative healthcare IT company.
Company Overview
Company Name
Redesign Science
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
180 Varick St.
New York, NY 10014
USA
New York, NY 10014
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Redesign Science develops and applies a molecular dynamics-driven platform for in silico drug discovery against emerging drug target classes. We work in partnership with Biotech and Pharma to co-develop novel small molecule therapeutics.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/16/2019
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Rooklin
Chief Technical Officer
Haotian Li
Company Investors
- Morningside Group
- Third Kind Venture Capital
- Refactor Capital
- Notation Capital (Nicholas Chirls)
- Private Investors (Thomas Weingarten)
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs